Kairous Acquisition (Kairous Acquisition) Current Accrued Expense : $0.00 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Kairous Acquisition Current Accrued Expense?

Kairous Acquisition's Current Accrued Expense for the quarter that ended in Mar. 2024 was $0.00 Mil.

Kairous Acquisition's quarterly Current Accrued Expense increased from Sep. 2023 ($0.00 Mil) to Dec. 2023 ($0.24 Mil) but then declined from Dec. 2023 ($0.24 Mil) to Mar. 2024 ($0.00 Mil).

Kairous Acquisition's annual Current Accrued Expense declined from Jun. 2021 ($0.02 Mil) to Jun. 2022 ($0.02 Mil) and declined from Jun. 2022 ($0.02 Mil) to Jun. 2023 ($0.00 Mil).

Kairous Acquisition Current Accrued Expense Historical Data

The historical data trend for Kairous Acquisition's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kairous Acquisition Current Accrued Expense Chart

Kairous Acquisition Annual Data

Trend

Jun21

Jun22

Jun23

Current Accrued Expense

0.02

Kairous Acquisition Quarterly Data
	Apr21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial							0.02	-	-	0.24	-

Kairous Acquisition Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Kairous Acquisition Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Kairous Acquisition's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.